CORONARY CONNECT
@coronaryconnect
COR2ED brings you Independent Medical Education developed by CORONARY CONNECT, international experts in coronary heart disease. cor2ed.com/community-guid…
ID: 1313791779842461696
https://cor2ed.com/connects/coronary-connect/ 07-10-2020 11:22:22
173 Tweet
785 Followers
331 Following
What’s new in lipid management? Find out in this update from AHA 2025 📺 Cardiologists Dr Robert Giugliano & Prof. Ulrich Laufs share expert insights on new data on lipid management They review data from VESALIUS-CV, VESALIUS-REAL, CORE-TIMI 72a/CORE2-TIMI 72b trials, and trials
What’s new in lipid management? Find out in this update from AHA 2025 📺 Cardiologists Dr Robert Giugliano & Prof. Ulrich Laufs share expert insights on new data on lipid management They review data from VESALIUS-CV, VESALIUS-REAL, CORE-TIMI 72a/CORE2-TIMI 72b trials, and trials
📢 Cardiology update! Lipid management highlights from AHA 2025 >> From Dr Robert Giugliano & Prof. Ulrich Laufs 📺 Watch the video in this post See more >> cor2ed.com/coronary-conne… 🤝 Endorsed by Fondazione Ticino Cuore & The Parole & Réaction patient group This educational
📣 Highlights from AHA 2025 Dr Robert Giugliano & Prof. Ulrich Laufs review data from: 🔸 VESALIUS-CV: Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke 🔸 VESALIUS-REAL: Stroke and Myocardial Infarction Rates in Patients
📢 Update on lipid management data from #AHA25 Dr Robert Giugliano & Prof. Ulrich Laufs joined us at AHA 2025 📺 Get their insights on data from VESALIUS-CV, VESALIUS-REAL, CORE-TIMI 72a/CORE2-TIMI 72b trials, and trials investigating CTX310 and DR10624 See more >>
Catch up on cardiology data from AHA 2025 📺 Dr Robert Giugliano & Prof. Ulrich Laufs share their lipid management highlights from AHA, reviewing key data from the VESALIUS-CV, VESALIUS-REAL, CORE-TIMI 72a/CORE2-TIMI 72b trials, and trials investigating CTX310 and DR10624 How will
📺Update on lipid management data from AHA 2025 Dr Robert Giugliano & Prof. Ulrich Laufs joined us at AHA 2025 Get their insights on data from VESALIUS-CV, VESALIUS-REAL, CORE-TIMI 72a/CORE2-TIMI 72b trials, and trials investigating CTX310 and DR10624 >> Endorsed by Fondazione
What’s new in lipid management? Cardiologists Dr Robert Giugliano & Prof. Ulrich Laufs share expert insights on recent data in lipid management from AHA 2025 📺 They review data from VESALIUS-CV, VESALIUS-REAL, CORE-TIMI 72a/CORE2-TIMI 72b trials, and trials investigating CTX310
📢 Lipid management highlights from AHA 2025 Expert insights from Dr Robert Giugliano & Prof. Ulrich Laufs 📺 Watch the video in this post See more & get the key clinical takeaways >> cor2ed.com/coronary-conne… 🤝 Endorsed by Fondazione Ticino Cuore & The Parole & Réaction patient
Heart attack warning signs everyone should know Heart attacks don’t always feel how you’d expect. Knowing the early signs can save a life. 📺This animated video was developed by cardiologists Prof. Gilles Montalescot & Prof. Marco Valgimigli (Marco Valgimigli ) It features a patient
Lipid management highlights from AHA 2025 Expert insights from Dr Robert Giugliano & Prof. Ulrich Laufs 📺 Watch the video in this post Endorsed by Fondazione Ticino Cuore & The Parole & Réaction patient group This educational programme is supported by an Independent Educational